TF and chronic kidney disease: Supplementation of SCFAs in CKD patients was found to result in a decrease in body ferritin concentration and a significant increase in transferrin saturation [156], and an improvement in haemoglobin levels, which subsequently improves the anaemic state of the patients with CKD.